Abstract

Review Article

Breast Cancer in Female

Lorena Menditto*

Published: 22 April, 2024 | Volume 8 - Issue 1 | Pages: 013-018

Anxiety is also a very common disorder, both in patients and their family members. Anxiety and stress can compromise the quality of life of cancer patients and their families. Feelings of anxiety and anguish can occur at various times of the disease path: during screening, waiting for test results, at diagnosis, during treatment or at the next stage due to concern about relapses. Anxiety and distress can affect the patient’s ability to cope with diagnosis or treatment, frequently causing reduced adherence to follow-up visits and examinations, indirectly increasing the risk of failure to detect a relapse, or a delay in treatment; and anxiety can increase the perception of pain, affect sleep, and accentuate nausea due to adjuvant therapies. Failure to identify and treat anxiety and depression in the context of cancer increases the risk of poor quality of life and potentially results in increased disease-related morbidity and mortality [1]. From all this we deduce the need and importance of dedicated psychological and psychiatric support for these patients within the Breast Unit. The fact that the psycho-oncologist who is dedicated to the care of patients with breast cancer must be an integrated figure in the multidisciplinary team of the Senological Center and not an external consultant is enshrined in the same European Directives that concern the legislation concerning the requirements that a Breast Unit must have in order to be considered a Full Breast Unit (Wilson AMR, et al. 2013).One of the most complex situations you find yourself dealing with is communication with the patient. This communication is particularly complex in two fragile subpopulations that are represented by women. [Menditto L. T (Tirannie) Cancer of the Breast. Am J Psychol & Brain Stud, 2023; 1(1):26-30].

Read Full Article HTML DOI: 10.29328/journal.acst.1001040 Cite this Article Read Full Article PDF

Keywords:

Panic/hypochondria; Depression; Induced menopause; Stiffness; Hypercontrol; Multidisciplinary approaches

References

  1. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011 Feb;12(2):160-74. doi: 10.1016/S1470-2045(11)70002-X. Epub 2011 Jan 19. PMID: 21251875.
  2. Manopola MT. The influence of endocrine effects of adjuvant therapy on quality of life in younger breast cancer survivors. The oncologist. 11(2): 96-110.
  3. Ganz, PA, Yip, CH, Gralow, JR, Distelhorst, SR, Albain, KS, Andersen, BL, Anderson BO. Supportive care after curative treatment for breast cancer (survivorship care): Resource allocation in low- and middle-income countries. A consensus statement from the Breast Health Global Initiative 2013. Breast. 2013; 22(5): 606-615.
  4. Annunziata MA, Muzzatti B, Flaiban C, Giovannini L, Carlucci M. Mood states in long-term cancer survivors: an Italian descriptive survey. Support Care Cancer. 2016 Jul;24(7):3157-64. doi: 10.1007/s00520-016-3134-1. Epub 2016 Mar 1. PMID: 26928442.
  5. Annunziata MA. Psychosocial assistance in oncology: the Italian reality. Health and Society. 2015/2.
  6. Henriksson MM, Isometsä ET, Hietanen PS, Aro HM, Lönnqvist JK. Mental disorders in cancer suicides. J Affect Disord. 1995 Dec 24;36(1-2):11-20. doi: 10.1016/0165-0327(95)00047-x. PMID: 8988260.
  7. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Carnicke CL. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249 (6), 751-757.
  8. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;(32):17-21. doi: 10.1093/jncimonographs/lgh023. PMID: 15263036.
  9. Walker J, Holm Hansen C, Martin P, Sawhney A, Thekkumpurath P, Beale C, Symeonides S, Wall L, Murray G, Sharpe M. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013 Apr;24(4):895-900. doi: 10.1093/annonc/mds575. Epub 2012 Nov 21. PMID: 23175625.
  10. Walker J, Sawhney A, Hansen CH, Symeonides S, Martin P, Murray G, Sharpe M. Treatment of depression in people with lung cancer: a systematic review. Lung Cancer. 2013; 79 (1), 46-53.
  11. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012 Dec 10;141(2-3):343-51. doi: 10.1016/j.jad.2012.03.025. Epub 2012 Jun 21. PMID: 22727334.
  12. Alicikus ZA, Gorken IB, Sen RC, Kentli S, Kinay M, Alanyali H, Harmancioglu O. Psychosexual and body image aspects of quality of life in Turkish patients with breast cancer: a comparison between breast-conserving treatment and mastectomy. Tumor Journal. 2009 ; 95 (2), 212-218.
  13. Lima SR, Junior VFV, Christo HB, Pinto AC e Fernandes PD. . In vivo and in vitro studies on the antitumor activity of Copaifera multijuga Hayne and its fractions. Phytotherapy Research: An international journal dedicated to the pharmacological and toxicological evaluation of natural product derivatives. 2003; 17(9): 1048-1053.
  14. Petit JY, Maisonneuve P, Rotmensz N, Bertolini F, Clough KB, Sarfati I, Gale KL, Macmillan RD, Rey P, Benyahi D, Rietjens M. Safety of Lipofilling in Patients with Breast Cancer. Clin Plast Surg. 2015 Jul;42(3):339-44, viii. doi: 10.1016/j.cps.2015.03.004. Epub 2015 Apr 28. PMID: 26116939.
  15. Tibaldi A. The animal tumor registry: do you have an idea what it is for?. Aivpa Journal. 5(3): 20-23. Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, Costa MJ, Fawole B, Mugerwa Y, Nafiou I, Neves I, Wolomby-Molondo JJ, Bang HT, Cheang K, Chuyun K, Jayaratne K, Jayathilaka CA, Mazhar SB, Mori R, Mustafa ML, Pathak LR, Perera D, Rathavy T, Recidoro Z, Roy M, Ruyan P, Shrestha N, Taneepanichsku S, Tien NV, Ganchimeg T, Wehbe M, Yadamsuren B, Yan W, Yunis K, Bataglia V, Cecatti JG, Hernandez-Prado B, Nardin JM, Narváez A, Ortiz-Panozo E, Pérez-Cuevas R, Valladares E, Zavaleta N, Armson A, Crowther C, Hogue C, Lindmark G, Mittal S, Pattinson R, Stanton ME, Campodonico L, Cuesta C, Giordano D, Intarut N, Laopaiboon M, Bahl R, Martines J, Mathai M, Merialdi M, Say L. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013 May 18;381(9879):1747-55. doi: 10.1016/S0140-6736(13)60686-8. PMID: 23683641.

Figures:

Similar Articles

  • Breast Cancer in Female
    Lorena Menditto* Lorena Menditto*. Breast Cancer in Female. . 2024 doi: 10.29328/journal.acst.1001040; 8: 013-018

Recently Viewed

Read More

Most Viewed

Read More

Help ?